Ubs Group Ag Io Biotech, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Io Biotech, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 3,280 shares of IOBT stock, worth $3,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,280

Holding current value

$3,476

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.17 - $1.71 $3,837 - $5,608	3,280 New	3,280 $3,000
Q4 2023 Feb 09, 2024	BUY	$0.84 - $1.95 $9,411 - $21,847	11,204 New	11,204 $21,000
Q2 2022 Aug 10, 2022	BUY	$3.79 - $8.38 $8,466 - $18,720	2,234 New	2,234 $10,000

Others Institutions Holding IOBT

# of Institutions

Shares Held

25.9M

Call Options Held

988K

Put Options Held

Vivo Capital, LLC Palo Alto, CA

6.17M
Shares

$6.54 Million
1.07% of portfolio
Novo Holdings Hellerup, G7

4.43M
Shares

$4.7 Million
0.37% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

3.64M
Shares

$3.86 Million
2.19% of portfolio
Pfm Health Sciences, LP San Francisco, CA

2.34M
Shares

$2.48 Million
0.14% of portfolio
Marshall Wace, LLP London, X0

2.11M
Shares

$2.23 Million
0.0% of portfolio

View Full List

About IO Biotech, Inc.

Ticker IOBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,815,300
Market Cap $30.5M
Description
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...

More about IOBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account